Dansk Selskab for Almen Medicin logoDansk Selskab for Almen Medicin logo
Klinisk vejledning

Publiseret: 2026

Astma og KOL

i almen praksis

Referencer

  1. About EBP – Resources for Evidence-Based Practice – Guides at McMaster University Health Sciences Library [Internet]. [henvist 21. oktober 2024]. Tilgængelig hos: https://hslmcmaster.libguides.com/ebm/ebp.

  2. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ. 13. januar 1996;312(7023):71–2. doi:10.1136/bmj.312.7023.71.

  3. Lundorf L. Dømmekraften i centrum. Practicus. december 2020;253.

  4. Dansk Selskab for Lungemedicin og Dansk Selskab for Klinisk Fysiologi og Nuklearmedicin. Dansk lungefunktionsstandard 2023 [Internet]. Tilgængelig hos: https://lungemedicin.dk/wp-content/uploads/2023/03/DLS-Samlet-160323.pdf.

  5. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention 2025. Tilgængelig hos: https://ginasthma.org/wp-content/uploads/2025/11/GINA-2025-Update-25_11_08-WMS.pdf.

  6. Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2026 GOLD Report and Pocket Guide. [Internet]. [henvist 6. juni 2026]. Tilgængelig hos: https://goldcopd.org/2026-gold-report-and-pocket-guide/.

  7. Fabricius P, Løkke A, Marott JL, Vestbo J, Lange P. Prevalence of COPD in Copenhagen. Respir Med. marts 2011;105(3):410–7. doi:10.1016/j.rmed.2010.09.019 PubMed PMID:20952174.

  8. Lykkegaard J, Kristensen GN. Chronic obstructive pulmonary disease in Denmark: Age-period-cohort analysis of first-time hospitalisations and deaths 1994-2012. Respir Med. maj 2016;114:78–83. doi:10.1016/j.rmed.2016.03.014 PubMed PMID: 27109815.

  9. Lykkegaard J, Søndergaard J, Kragstrup J, Rømhild Davidsen J, Knudsen T, Andersen M. All Danish first-time COPD hospitalisations 2002-2008: incidence, outcome, patients, and care. Respir Med. april 2012;106(4):549–56. doi:10.1016/j.rmed.2011.11.001 PubMed PMID: 22115929.

  10. Lykkegaard J, Davidsen JR, Paulsen MS, Andersen M, Søndergaard J. On the crest of a wave: Danish prevalence of hospitalisation-required COPD 2002-2009. Respir Med. oktober 2012;106(10):1396–403. doi:10.1016/j.rmed.2012.06.004 PubMed PMID: 22749753.

  11. Dansk Register for Astma. DrAstma Årsrapport 2022. RKKP.

  12. Dansk Register for Kronisk Obstruktiv Lungesygdom. Årsrapport 2022. RKKP.

  13. Backer V, Sverrild A, Ulrik CS, Bødtger U, Seersholm N, Porsbjerg C. Diagnostic work-up in patients with possible asthma referred to a university hospital. Eur Clin Respir J. 7. juli 2015;2:10.3402/ecrj.v2.27768. doi:10.3402/ecrj.v2.27768 PubMed PMID: 26557251; Pub-Med Central PMCID: PMC4629726.

  14. Dansk Lungemedicinsk Selskab. Astma – Diagnostik – DLS [Internet]. [henvist 27. september 2024]. Tilgængelig hos: https://lungemedicin.dk/astma-diagnostik/

  15. Aaron SD, Vandemheen KL, FitzGerald JM, Ainslie M, Gupta S, Lemière C, m.fl. Reevaluation of Diagnosis in Adults With Physician-Diagnosed Asthma. JAMA. 17. januar 2017;317(3):269–79. doi:10.1001/jama.2016.19627.

  16. Backer V, Stensen L, Sverrild A, Wedge E, Porsbjerg C. Objective confirmation of asthma diagnosis improves medication adherence. J Asthma Off J Assoc Care Asthma. november 2018;55(11):1262–8. doi:10.1080/02770903.2017.1410830 PubMed PMID: 29278942.

  17. Dansk Lungemedicinsk Selskab (DLS). Rygeophør [Internet]. [henvist 16. januar 2026]. Tilgængelig hos: https://lungemedicin.dk/rygeophoer/

  18. Dansk Lungemedicinsk Selskab (DLS). KOL – Behandling i stabil fase [Internet]. [henvist 27. september 2024]. Tilgængelig hos: https://lungemedicin.dk/kol-behandling-i-stabil-fase/.

  19. Dansk Lungemedicinsk Selskab (DLS). Astma – Monitorering og behandling af mild til moderat astma [Internet]. [henvist 21. oktober 2024]. Tilgængelig hos: https://lungemedicin.dk/astma-monitorering-og-behandling-af-mild-til-moderat-astma/.

  20. Montes de Oca M. Smoking Cessation/Vaccinations. Clin Chest Med. september 2020;41(3):495–512. doi:10.1016/j.ccm.2020.06.013 PubMed PMID: 32800202.

  21. Taylor GM, Lindson N, Farley A, Leinberger-Jabari A, Sawyer K, Naudé R te W, m.fl. Smoking cessation for improving mental health - Taylor, GMJ - 2021 | Cochrane Library [Internet]. [henvist 12. april 2026]. Tilgængelig hos: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013522.pub2/full

  22. Sundhedsstyrelsen. Tobak og nikotin [Internet]. [henvist 25. november 2024]. Tilgængelig hos: http://www.sst.dk/da/Fagperson/Forebyggelse-og-tvaergaaende-indsatser/Tobak-og-nikotin. OBS: IKKE LÆNGERE TILGÆNGELIG PÅ LINKET.

  23. Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 31. maj 2018;5(5):CD000146. doi:10.1002/14651858.CD000146.pub5.

  24. Theodoulou A, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J, m.fl. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 19. juni 2023;2023(6):CD013308. doi:10.1002/14651858.CD013308.pub2.

  25. Livingstone-Banks J, Fanshawe TR, Thomas KH, Theodoulou A, Hajizadeh A, Hartman L, m.fl. Nicotine receptor partial agonists for smoking cessation - Livingstone-Banks, J - 2023 | Cochrane Library [Internet]. [henvist 12. april 2026]. Tilgængelig hos: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006103.pub9/full.

  26. Walker N, Howe C, Glover M, McRobbie H, Barnes J, Nosa V, m.fl. Cytisine versus nicotine for smoking cessation. N Engl J Med. 18. december 2014;371(25):2353–62. doi:10.1056/NEJMoa1407764.

  27. Hajizadeh A, Howes S, Theodoulou A, Klemperer E, Hartmann-Boyce J, Livingstone-Banks J, m.fl. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 24. maj 2023;5(5):CD000031. doi:10.1002/14651858.CD000031.pub6.

  28. Thomas KH, Dalili MN, López-López JA, Keeney E, Phillippo DM, Munafò MR, m.fl. Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta-analysis of randomized controlled trials. Addict Abingdon Engl. april 2022;117(4):861–76. doi:10.1111/add.15675.

  29. Rose JJ, Krishnan-Sarin S, Exil VJ, Hamburg NM, Fetterman JL, Ichinose F, m.fl. Cardiopulmonary Impact of Electronic Cigarettes and Vaping Products: A Scientific Statement From the American Heart Association. Circulation. 22. august 2023;148(8):703–28. doi:10.1161/CIR.0000000000001160.

  30. Sun Y, Lin K, Effah F, Cartujano Barrera F, Li D, McIntosh S, m.fl. Toxicity of humectants propylene glycol and vegetable glycerin in electronic nicotine delivery systems. Toxicol Lett. november 2025;413:111739. doi:10.1016/j.toxlet.2025.111739.

  31. Wills TA, Soneji SS, Choi K, Jaspers I, Tam EK. E-cigarette use and respiratory disorders: an integrative review of converging evidence from epidemiological and laboratory studies. Eur Respir J. januar 2021;57(1):1901815. doi:10.1183/13993003.01815-2019.

  32. Wills TA, Choi K, Pokhrel P, Pagano I. Tests for confounding with cigarette smoking in the association of E-cigarette use with respiratory disorder: 2020 National-Sample Data. Prev Med. august 2022;161:107137. doi:10.1016/j.ypmed.2022.107137.

  33. Tashkin DP. Is Smoked Marijuana a Risk Factor for Chronic Obstructive Pulmonary Disease? An Enduring Controversy. Ann Am Thorac Soc. november 2024;21(11):1474–9. doi:10.1513/AnnalsATS.202405-478PS.

  34. De fysiske gevinster ved at blive røgfri - Kræftens Bekæmpelse [Internet]. [henvist 25. november 2024]. Tilgængelig hos: https://www.cancer.dk/forebyg-kraeft/tobak-og-nikotin/rygestop-og-nikotinstop/fysiske-gevinster-roegfri/.

  35. Hansen ESH, Pitzner-Fabricius A, Toennesen LL, Rasmusen HK, Hostrup M, Hellsten Y, m.fl. Effect of aerobic exercise training on asthma in adults: a systematic review and meta-analysis. Eur Respir J. juli 2020;56(1):2000146. doi:10.1183/13993003.00146-2020.

  36. Webber EM, Lin JS, Thomas RG. Screening for Chronic Obstructive Pulmonary Disease: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 10. maj 2022;327(18):1812–6. doi:10.1001/jama.2022.4708.

  37. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease - 2015 | Cochrane Library [Internet]. [henvist 21. oktober 2024]. Tilgængelig hos: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003793.pub3/full.

  38. Puhan MA, Gimeno-Santos E, Cates CJ, Troosters T. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 8. december 2016;12(12):CD005305. doi:10.1002/14651858.CD005305.pub4.

  39. Jenkins AR, Burtin C, Camp PG, Lindenauer P, Carlin B, Alison JA, m.fl. Do pulmonary rehabilitation programmes improve outcomes in patients with COPD posthospital discharge for exacerbation: a systematic review and meta-analysis. Thorax. 15. april 2024;79(5):438–47. doi:10.1136/thorax-2023-220333.

  40. Cates CJ, Rowe BH. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev. 28. februar 2013;2013(2):CD000364. doi:10.1002/14651858.CD000364.pub4.

  41. Kopsaftis Z, Wood-Baker R, Poole P. Influenza vaccine for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev. 26. juni 2018;6(6):CD002733. doi:10.1002/14651858.CD002733.pub3.

  42. Bekkat-Berkani R, Wilkinson T, Buchy P, Dos Santos G, Stefanidis D, Devaster JM, m.fl. Seasonal influenza vaccination in patients with COPD: a systematic literature review. BMC Pulm Med. 3. maj 2017;17(1):79. doi:10.1186/s12890-017-0420-8.

  43. Walters JA, Tang JNQ, Poole P, Wood-Baker R. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 24. januar 2017;1(1):CD001390. doi:10.1002/14651858.CD001390.pub4.

  44. Thompson MG, Stenehjem E, Grannis S, Ball SW, Naleway AL, Ong TC, m.fl. Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings. N Engl J Med. 7. oktober 2021;385(15):1355–71. doi:10.1056/NEJMoa2110362.

  45. Lichscheidt ED, Harboe ZB, Fischer TK, Larsen CS. Vaccines against respiratory syncytial virus. Ugeskr Læg. 11. marts 2024;186:1–7. doi:10.61409/V12230800.

  46. Britton A. Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices – United States, 2024. MMWR Morb Mortal Wkly Rep. 2024;73. doi:10.15585/mmwr.mm7332e1.

  47. Buck PO, Meyers JL, Gordon LD, Parikh R, Kurosky SK, Davis KL. Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claims. Epidemiol Infect. juli 2017;145(10):2109–21. doi:10.1017/S0950268817000887.

  48. Wang M, Ni X, Yu F. Impact of Body Mass Index on Risk of Exacerbation in Patients With COPD: A Systematic Review and Meta-Analysis. Chronic Obstr Pulm Dis. 27. september 2024;11(5):524–33. doi:10.15326/jcopdf.2024.0507.

  49. Huang WJ, Ko CY. Systematic review and meta-analysis of nutrient supplements for treating sarcopenia in people with chronic obstructive pulmonary disease. Aging Clin Exp Res. 14. marts 2024;36(1):69. doi:10.1007/s40520-024-02722-w.

  50. Rabec C, Janssens JP, Murphy PB. Ventilation in the obese: physiological insights and management. Eur Respir Rev Off J Eur Respir Soc. april 2025;34(176):240190. doi:10.1183/16000617.0190-2024.

  51. Kew KM, Nashed M, Dulay V, Yorke J. Cognitive behavioural therapy (CBT) for adults and adolescents with asthma. Cochrane Database Syst Rev. 21. september 2016;9(9):CD011818. doi:10.1002/14651858.CD011818.pub2.

  52. Williams MT, Johnston KN, Paquet C. Cognitive Behavioral Therapy for People with Chronic Obstructive Pulmonary Disease: Rapid Review. Int J Chron Obstruct Pulmon Dis. 2020;15:903–19. doi:10.2147/COPD.S178049.

  53. Buican IL, Buican-Chirea AC, Mușat MI, Streba CT. Depression and Anxiety as Comorbidities in Chronic Obstructive Pulmonary Disease: A Comprehensive Narrative Review. Healthcare. 18. september 2025;13(18):2344. doi:10.3390/healthcare13182344.

  54. Laguna-Muñoz D, Pata MP, Jiménez-Peinado A, Jaén-Moreno MJ, Camacho-Rodríguez C, Del Pozo GI, m.fl. Mortality from respiratory diseases in individuals with severe mental illness: a large-scale systematic review and meta-analysis of pooled and specific diagnoses. Lancet Psychiatry. oktober 2025;12(10):768–79. doi:10.1016/S2215-0366(25)00262-7.

  55. Jørgensen M, Mainz J, Lange P, Paaske Johnsen S. Quality of care and clinical outcomes of chronic obstructive pulmonary disease in patients with schizophrenia. A Danish nationwide study. Int J Qual Health Care J Int Soc Qual Health Care. 1. juni 2018;30(5):351–7. doi:10.1093/intqhc/mzy014.

  56. Adams NP, Bestall JC, Lasserson TJ, Jones PW, Cates C. Fluticasone versus placebo for chronic asthma in adults and children. Cochrane Database Syst Rev. 19. oktober 2005;(4):CD003135. doi:10.1002/14651858.CD003135.pub3.

  57. Teelucksingh S, Davis A, Nelson-Piercy C. Asthma and Pregnancy: A Narrative Review. CHEST. 25. september 2025;0(0). doi:10.1016/j.chest.2025.08.043.

  58. Astma – Akut – DLS | Dansk Lungemedicinsk Selskab [Internet]. [henvist 29. november 2024]. Tilgængelig hos: https://lungemedicin.dk/astma-akut/.

  59. Geffen WH van, Tan DJ, Walters JA, Walters EH. Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease - 2023 | Cochrane Library [Internet]. [henvist 22. januar 2026]. Tilgængelig hos: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011600.pub3/full.

  60. Zhang C, Zhang M, Wang Y, Xiong H, Huang Q, Shuai T, m.fl. Efficacy and cardiovascular safety of LAMA in patients with COPD: a systematic review and meta-analysis. J Investig Med Off Publ Am Fed Clin Res. december 2021;69(8):1391–8. doi:10.1136/jim-2021-001931.

  61. Ni H, Htet A, Moe S. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD) - 2017 | Cochrane Library [Internet]. [henvist 22. januar 2026]. Tilgængelig hos: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011897.pub2/full.

  62. Karner C, Chong J, Poole P. Tiotropium versus placebo for chronic obstructive pulmonary disease - 2014 | Cochrane Library [Internet]. [henvist 22. januar 2026]. Tilgængelig hos: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009285.pub3/full.

  63. Bateman ED, Chapman KR, Singh D, D’Urzo AD, Molins E, Leselbaum A, m.fl. Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT). Respir Res. 2. august 2015;16(1):92. doi:10.1186/s12931-015-0250-2.

  64. Dansk Lungemedicinsk Selskab (DLS). KOL – exacerbation og NIV – DLS | [Internet]. [henvist 29. november 2024]. Tilgængelig hos: https://lungemedicin.dk/kol-exacerbation-og-niv/.

  65. Reilev M, Lykkegaard J, Halling A, Vestbo J, Søndergaard J, Pottegård A. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide registerbased study. NPJ Prim Care Respir Med. 17. april 2017;27(1):25. doi:10.1038/s41533-017-0029-7.

  66. Llor C, Moragas A, Miravitlles M, Mesquita P, Cordoba G. Are short courses of antibiotic therapy as effective as standard courses for COPD exacerbations? A systematic review and meta-analysis. Pulm Pharmacol Ther. februar 2022;72:102111. doi:10.1016/j.pupt.2022.102111.

  67. Llor C, Moragas A, Hernández S, Bayona C, Miravitlles M. Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 15. oktober 2012;186(8):716–23. doi:10.1164/rccm.201206-0996OC.

  68. Ramakrishnan S, Jeffers H, Langford-Wiley B, Davies J, Thulborn SJ, Mahdi M, m.fl. Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial. Lancet Respir Med. januar 2024;12(1):67–77. doi:10.1016/S2213-2600(23)00298-9.

  69. Gkini E, De Soyza J, Spittle DA, Ellis PR, Tearne S, Adab P, m.fl. Sputum colour charts to guide antibiotic self-treatment of acute exacerbation of chronic obstructive pulmonary disease: the Colour-COPD RCT. BMJ Open Respir Res. 10. oktober 2025;12(1):e003615. doi:10.1136/bmjresp-2025-003615.

  70. Lange P, Nielsen LP. Inhalationssystemer. Information til sundhedsfaglige - Medicin.dk [Internet]. [henvist 23. januar 2026]. Tilgængelig hos: https://pro.medicin.dk/Laegemiddelgrupper/Grupper/315301.

  71. Chen H, Sun J, Huang Q, Liu Y, Yuan M, Ma C, m.fl. Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials. Front Pharmacol. 2021;12:691621. doi:10.3389/fphar.2021.691621.

  72. Pu X, Zhang Y, Peng L, Huang Y, Jiang X, Wang M, m.fl. Adverse events of inhaled corticosteroids in adult patients with asthma or chronic obstructive pulmonary disease: pairwise, network and dose-response meta-analyses. BMJ Evid-Based Med. 21. januar 2026;31(1):23–35. doi:10.1136/bmjebm-2024-113216.

  73. von Bülow A, Hansen S, Sandin P, Cooper A, Ernstsson O, Geale K, m.fl. Use of High-Dose Inhaled Corticosteroids and Risk of Corticosteroid-Related Adverse Events in Asthma Findings From the NORDSTAR Cohort. J Allergy Clin Immunol Pract. juli 2025;13(7):1609-1619.e5. doi:10.1016/j.jaip.2025.01.023.

  74. Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. oktober 2006;81(10):1361–7. doi:10.4065/81.10.1361.

  75. Dansk Endokrinologisk Selskab. Osteoporose [Internet]. [henvist 22. januar 2026]. Tilgængelig hos: https://endocrinology.dk/nbv/calcium-og-knoglemetabolisme/postmenopausal-osteoporose/.

  76. Dansk Lungemedicinsk Selskab (DLS). LT_NIV (Hjemme-NIV til KOL-patienter) – DLS [Internet]. [henvist 7. august 2026]. Tilgængelig hos: https://lungemedicin.dk/kol-lt-nivhjemme-niv/.

  77. Dansk Lungemedicinsk Selskab (DLS). Iltbehandling i hjemmet – DLS [Internet]. [henvist 29. november 2024]. Tilgængelig hos: https://lungemedicin.dk/iltbehandling-i-hjemmet/.

  78. Lommatzsch M, Brusselle GG, Levy ML, Canonica GW, Pavord ID, Schatz M, m.fl. A2BCD: a concise guide for asthma management. Lancet Respir Med. 1. juni 2023;11(6):573–6. doi:10.1016/S2213-2600(22)00490-8.

  79. Hains I, Meyers J, Sterling K, Yoo J, Reddel H, Weston C. Difficult-to-treat and severe asthma in general practice: delivery and evaluation of an educational program. BMC Fam Pract. 13. juli 2019;20:99. doi:10.1186/s12875-019-0991-y.

  80. Cloutier MM, Dixon AE, Krishnan JA, Lemanske RF, Pace W, Schatz M. Managing Asthma in Adolescents and Adults: 2020 Asthma Guideline Update From the National Asthma Education and Prevention Program. JAMA. 8. december 2020;324(22):2301–17. doi:10.1001/jama.2020.21974.

  81. Eichenlaub M, Frye BC, Lehrmann H, Biertz F, Jadidi AS, Kaier K, m.fl. ECG-based identification of COPD patients at risk for atrial fibrillation and its impact on adverse clinical outcomes-a subgroup analysis of the prospective multicenter COSYCONET cohort. Respir Res. 17. september 2025;26(1):272. doi:10.1186/s12931-025-03342-2.

  82. Dansk Selskab for Almen Medicin. Palliation [Internet]. 2025 [henvist 22. januar 2026]. Tilgængelig hos: https://www.dsam.dk/vejledninger/palliation/10-lindring-af-symptomer-og-tilstande.

  83. Marså K, Knudsen T, Gundestrup S, Thorsen E, Larsen H, Kirkegaard N, m.fl. Dansk Lungemedicinsk Selskab: Klaringsrapport om palliation til voksne med kronisk fremadskridende non-malign lungesygdom. Tilgængelig hos: https://lungemedicin.dk/wp-content/uploads/2021/06/DLS-klaringsrapport-om-palliation-2015.pdf.

  84. Marså K, Lavesen M, Knudsen T, Gundestrup S, Thorsen ME m.fl. Dansk Lungemedicinsk Selskab: Samtalen om Fælles Planlægning af Behandlingsmål (Klaringsrapport) [Internet]. Tilgængelig hos: https://lungemedicin.dk/wp-content/uploads/2021/06/DLS-Faelles-planlaegning-af-behandlingsmaal-2015.pdf.